Biogen Stock Surges on Competitor's Downbeat Drug Data

Biogen released upbeat Alzheimer's drug data in September

Digital Content Manager
Nov 14, 2022 at 10:57 AM
facebook X logo linkedin


While several sectors are taking a breather this morning, Biogen Inc (NASDAQ:BIIB) is climbing after major competitor Roche (ROG) said that its Alzheimer's drug candidate, gantenerumab, failed to meet its main goal. Back in September, Biogen shared upbeat data for its own Alzheimer's treatment, which caused the shares to surge, landing a series of highs in the subsequent months. Today, BIIB notched a one-year high of $304.56, and was last seen up 4.9% at $303.54. 

This surge puts BIIB above a recent ceiling at the $293 level, which pressured shares lower in October 2021 as well. The equity now boasts a 27.2% year-to-date lead, and has added 12.9% in the last 12 months.

Options traders are taking note of the positive price action. So far, 4,640 calls have exchanged hands, which is triple what's typically seen at this point, compared to 1,933 puts. The most popular is the November 300 call, followed closely by the December 300 call. 

Despite its recent positive price action, short-term options players have been incredibly put-biased. This is per the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.99, which sits higher than 77% of readings from the past year. 

There are still some holdouts among the brokerage bunch, too. Of the 27 analysts in coverage, nine still sport a "hold" rating, while the 12-month consensus price target of $305.78 is in line with current levels. 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI